PCA
Pallas Capital Advisors Portfolio holdings
AUM
$2.63B
1-Year Return
7.61%
This Quarter Return
+9.01%
1 Year Return
+7.61%
3 Year Return
+38.25%
5 Year Return
–
10 Year Return
–
AUM
$2.63B
AUM Growth
+$217M
(+9%)
Cap. Flow
+$71.4M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
947
New
185
Increased
338
Reduced
311
Closed
89
Top Buys
Top Sells
| 1 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$20M |
| 2 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
+$19.4M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$10.5M |
| 4 |
Broadcom
AVGO
|
+$8.45M |
| 5 |
Synopsys
SNPS
|
+$7.4M |
Sector Composition
| 1 | Healthcare | 20.15% |
| 2 | Technology | 14.42% |
| 3 | Financials | 7.34% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Coty
COTY
$3.73B
| $52.1K | ﹤0.01% |
11,199
-28,974
| -72% | -$135K |
|
827
Xeris Biopharma Holdings
XERS
$1.22B
| $51.4K | ﹤0.01% |
11,005
-4,338
| -28% | -$20.3K |
|
828
Cytek Biosciences
CTKB
$515M
| $47.8K | ﹤0.01% |
+14,069
| New | +$47.8K |
|
829
Transocean
RIG
$2.99B
| $45.6K | ﹤0.01% |
17,600
+478
| +3% | +$1.24K |
|
830
Critical Metals Corp
CRML
$589M
| $44.7K | ﹤0.01% |
+12,481
| New | +$44.7K |
|
831
Open Lending Corp
LPRO
$256M
| $44.4K | ﹤0.01% |
+22,891
| New | +$44.4K |
|
832
Conduent
CNDT
$447M
| $43.4K | ﹤0.01% |
+16,432
| New | +$43.4K |
|
833
Ardagh Metal Packaging
AMBP
$2.09B
| $43.4K | ﹤0.01% |
+10,132
| New | +$43.4K |
|
834
Humacyte
HUMA
$231M
| $41.5K | ﹤0.01% |
+19,877
| New | +$41.5K |
|
835
Taboola.com
TBLA
$1.01B
| $40.7K | ﹤0.01% |
+11,130
| New | +$40.7K |
|
836
Ventyx Biosciences
VTYX
$171M
| $38.1K | ﹤0.01% |
+17,824
| New | +$38.1K |
|
837
Sera Prognostics
SERA
$114M
| $38K | ﹤0.01% |
13,711
-146
| -1% | -$404 |
|
838
Lexicon Pharmaceuticals
LXRX
$407M
| $34.8K | ﹤0.01% |
36,765
+557
| +2% | +$527 |
|
839
SmartRent
SMRT
$276M
| $30.5K | ﹤0.01% |
30,788
+17,312
| +128% | +$17.1K |
|
840
Mersana Therapeutics
MRSN
$35.5M
| $28.6K | ﹤0.01% |
3,868
+87
| +2% | +$644 |
|
841
Leslie's
LESL
$62M
| $26.8K | ﹤0.01% |
63,888
+40,100
| +169% | +$16.8K |
|
842
SES AI
SES
$413M
| $23.8K | ﹤0.01% |
26,773
-242
| -0.9% | -$215 |
|
843
Nkarta
NKTX
$148M
| $21.3K | ﹤0.01% |
12,836
-305
| -2% | -$506 |
|
844
Tilray
TLRY
$1.27B
| $21K | ﹤0.01% |
50,723
-16,944
| -25% | -$7.02K |
|
845
ChargePoint
CHPT
$244M
| $18.6K | ﹤0.01% |
1,323
-4,624
| -78% | -$65K |
|
846
Fate Therapeutics
FATE
$109M
| $17.2K | ﹤0.01% |
15,336
+1,104
| +8% | +$1.24K |
|
847
GoPro
GPRO
$259M
| $16.9K | ﹤0.01% |
22,293
-4,645
| -17% | -$3.52K |
|
848
Tenaya Therapeutics
TNYA
$212M
| $16.4K | ﹤0.01% |
26,832
-168
| -0.6% | -$103 |
|
849
Hain Celestial
HAIN
$174M
| $15.8K | ﹤0.01% |
+10,403
| New | +$15.8K |
|
850
Erasca
ERAS
$448M
| $15.7K | ﹤0.01% |
12,325
+815
| +7% | +$1.04K |
|